GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Allergan Plc (AGN) [hlAlert]

Rating:
Outperform
AGN
up 181.54 %

Allergan, Inc. (AGN) rated Outperform with price target $117 by BMO Capital Markets

Posted on: Friday,  Dec 20, 2013  1:25 PM ET by BMO Capital Markets

BMO Capital Markets rated Outperform Allergan, Inc. (NYSE: AGN) on 12/20/2013, when the stock price was $108.68. Since
then, Allergan, Inc. has gained 181.54% as of 11/24/2015's recent price of $305.98.
If you would have followed this BMO Capital Markets's recommendation on AGN, you would have gained 181.54% of your investment in 704 days.

Allergan, Inc. is a multi-specialty health care company focused on developing and commercializing pharmaceuticals, biologics and medical devices. The Company is engaged in discovering, developing and commercializing specialty pharmaceutical, medical device and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological and other specialty markets in more than 100 countries globally. In January 2007, the Company completed the acquisition of Groupe Corneal Laboratoires (Corneal). In October 2007, the Company completed the acquisition of Esprit Pharma Holding Company, Inc. (Esprit). In July 2008, the Company acquired the Aczone (dapsone) gel 5% from QLT USA, Inc. (QLT), a wholly owned subsidiary of QLT Inc. The Company operates in two business segments: specialty pharmaceuticals and medical devices.

The U.S. Equity Research team comprises over 25 analysts located in New York, Atlanta, Boston, Denver, Houston and Los Angeles. We cover more than 375 stocks and also provide equity strategy, quantitative analysis and portfolio management services to our clients. Our goal is to identify the best sectors to invest in, and the best stocks within those sectors, in order to help our clients maximize their portfolio returns. Our award-winning analysts provide research that is informative, perceptive and actionable.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/20/2013 1:25 PM Buy
None
108.68 117.00
as of 8/27/2015
1 Week down  -2.59 %
1 Month up  47.23 %
3 Months up  33.64 %
1 YTD up  181.53 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy